FIELD: medicine.
SUBSTANCE: fetal sex determination method includes Anti-Mullerian Hormone (AMH) level determination in the blood serum, on week 7 and 9-10 of gestation, and in case of AMH increase 2.6 or more times in this period, presence of a male fetus is diagnosed, in case of an increase not higher than 1.5 times - presence of a female fetus is diagnosed.
EFFECT: method can accurately diagnose fetus sex in early pregnancy.
4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR EVALUATING SEVERITY OF PREECLAMPSIA | 2012 |
|
RU2478966C1 |
| METHOD FOR SELECTING FEMALE PATIENTS WITH POOR OVARIAN RESERVE FOR EGG DONATION PROGRAMME | 2014 |
|
RU2565449C1 |
| METHOD FOR PREDICTION OF CLINICAL OUTCOMES OF EF AND ET PROGRAMS | 2015 |
|
RU2581027C1 |
| METHOD OF PRE-CLINICAL DIAGNOSTICS OF PREMATURE OF OVARIANS IN WOMEN OF REPRODUCTIVE AGE | 2016 |
|
RU2625723C1 |
| METHOD FOR PREDICTION OF PLACENTAL INSUFFICIENCY IN SECOND TRIMESTER OF PREGNANCY | 2014 |
|
RU2554827C1 |
| METHOD FOR PREDICTING RESULTS OF AUXILIARY REPRODUCTIVE TECHNOLOGIES IN TUBAL INFERTILITY | 2017 |
|
RU2672267C1 |
| METHOD FOR PREDICTION OF PREECLAMPSIA IN PREGNANT WOMEN WITH GESTATIONAL DIABETES MELLITUS | 2020 |
|
RU2740852C1 |
| METHOD FOR PREDICTING PREMATURE RUPTURE OF MEMBRANES BEFORE 28 WEEKS OF GESTATION | 2020 |
|
RU2752550C1 |
| METHOD FOR PERSONALISED TREATMENT OF OVARIAN ENDOMETRIOSIS IN WOMEN OF REPRODUCTIVE AGE BASED ON A POINT DIAGNOSTIC SYSTEM | 2021 |
|
RU2761982C1 |
| METHOD FOR FETOPLACENTAL INSUFFICIENCY PREDICTION IN PREGNANT WOMEN WITH ANDROIDS TYPE OF OBESITY | 2020 |
|
RU2738708C1 |
